Close Menu
Home › US District Court Sides With Roche, Ariosa in NIPT Patent Case Filed by Illumina

US District Court Sides With Roche, Ariosa in NIPT Patent Case Filed by Illumina

Dec 27, 2018
|
staff reporter

NEW YORK (GenomeWeb) – A US District Court has thrown out a patent infringement suit brought by Illumina against Ariosa Diagnostics and parent company Roche regarding non-invasive prentatal testing technologies.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

What's Popular?

In Molecular Diagnostics

  1. Quest Diagnostics Acquires Blueprint Genetics

  2. Multi-Disease Diagnostic Platform Project Receives €22.5M in EU Funding

  3. Adaptive Biotechnologies Announces Preliminary FY19 Revenue Increase, $257M Stock Offering

  4. Inotrem, Roche Diagnostics Enter Licensing Agreement for Septic Shock CDx

  5. Novigenix-led Collaboration Receives €1M European Funding for Colorectal Cancer Multi-Omics Research

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.